VivoSim Labs
VIVS
37 hedge funds and large institutions have $7.42M invested in VivoSim Labs in 2022 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 11 reducing their positions, and 9 closing their positions.
0.23% less ownership
Funds ownership: 2.17% → 1.94% (-0.23%)
10% less capital invested
Capital invested by funds: $8.23M → $7.42M (-$811K)
20% less funds holding
Funds holding: 46 → 37 (-9)
82% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 11
89% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$31.6K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$291 |
| 3 |
GEA
Glen Eagle Advisors
Kingston,
New Jersey
|
+$42 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$263K |
| 2 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
-$200K |
| 3 |
Renaissance Technologies
New York
|
-$123K |
| 4 |
Two Sigma Investments
New York
|
-$87K |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$83.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GEA
26
Glen Eagle Advisors
Kingston,
New Jersey
| $45 | +$42 | +1 | New |
|
|
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $11 | – | – | – |
|
|
PGCM
28
Prescott Group Capital Management
Tulsa,
Oklahoma
| – | -$200K | -4,598 | Closed |
|
|
29
Two Sigma Investments
New York
| – | -$87K | -1,989 | Closed |
|
30
Two Sigma Advisers
New York
| – | -$39K | -889 | Closed |
|
|
TRCT
31
Tower Research Capital (TRC)
New York
| – | -$6.82K | -164 | -94% |
|
32
Simplex Trading
Chicago,
Illinois
| – | -$1.29K | -31 | Closed |
|
33
Group One Trading
Chicago,
Illinois
| – | -$208 | -5 | Closed |
|
|
PP
34
PFS Partners
Mine Hill,
New Jersey
| – | -$182 | -4 | Closed |
|
VIVS Hedge Fund Activity: Q1 2022 in Review
37 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q1 2022, worth a combined $7.42M — down 9.8% from $8.23M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of VIVS and 1 opened new positions — a net loss of 8 holders — while 11 trimmed existing stakes and 2 added.
The largest buyer was Susquehanna International Group, adding an estimated $31.6K. The largest seller was Vanguard Group, cutting an estimated $263K.
- 37 institutional investors held VivoSim Labs (VIVS) as of Q1 2022, down from 46 in Q4 2021.
- Funds reported $7.42M of VivoSim Labs stock for Q1 2022, down 9.8% quarter-over-quarter.
- 1 fund opened new VivoSim Labs positions in Q1 2022 and 9 closed out, a net change of -8 holders.
- The largest VivoSim Labs buyer in Q1 2022 was Susquehanna International Group, an estimated $31.6K added.
- The largest VivoSim Labs seller in Q1 2022 was Vanguard Group, an estimated $263K sold.
Based on aggregated 13F filings for Q1 2022.